Author:
eczemarelief
Deucravacitinib Shows Significant Efficacy and Safety in Phase 3b/4 Trial for Moderate to Severe Scalp Psoriasis – Dermatology Times
eczemarelief
October 28, 2024
Available Therapeutics and Upcoming Advancements in Atopic Dermatitis and Prurigo Nodularis – Dermatology Times
eczemarelief
October 26, 2024
Eczema Awareness Month 2024: The Ecz-hibition – National Eczema Association
eczemarelief
October 24, 2024
Study finds link between eczema and peripheral vascular disease – Medical Xpress
eczemarelief
October 22, 2024